← Leaderboards
David Edward Sleat
Rbhs-Robert Wood Johnson Medical School
$1,432,298
Attributed
$1,432,298
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $497.5K · FY2015–23$500K$375K$250K$125K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$1,432,298 · 2
By mechanism
R01$995,048 · 1
R21$437,250 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Treatment Efficacy”
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$239,767,754
- Judith S. Currier · University Of California Los Angeles$224,898,605
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$222,287,773
- Sharon A Nachman · Johns Hopkins University$213,337,729
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$200,360,009
- Lawrence Corey · Fred Hutchinson Cancer Center$163,868,320
Research focus
Treatment EfficacyNeuronsSeizuresSpielmeyer-Vogt DiseaseProteomicsProteinsRegimenEffective TherapyMeasurableMutationPhenotypeBiochemicalProgressive NeurodegenerationBiological MarkersBrainNeurodegenerative DisordersCessation Of LifeChildBlindnessMass Spectrum AnalysisMouse ModelMonitorPotential BiomarkerBase
Grant awards (4)
Novel Lysosomal Enzyme Deficient in Batten Disease$497,524
R01 · FY2023 · NS · contact PI
Novel Lysosomal Enzyme Deficient in Batten Disease$497,524
R01 · FY2022 · NS · contact PI
Biomarker discovery for juvenile neuronal ceroid lipofuscinosis$238,500
R21 · FY2016 · NS · contact PI
Biomarker discovery for juvenile neuronal ceroid lipofuscinosis$198,750
R21 · FY2015 · NS · contact PI